$ATRX Adhera Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Adhera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adhera Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Adhera Therapeutics, Inc. for free.
IRS Number: 112658569
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ATRX
Company Address: P.O. BOX 2161 WAKE FOREST 27588
Phone number: 919-518-3748
Former name: NASTECH PHARMACEUTICAL CO INC, date of change: 1992-07-03
Former name: MDRNA, Inc., date of change: 2008-06-10
Former name: Marina Biotech, Inc., date of change: 2010-07-22
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Market Capitalization: $626850.00
Prev close: $0.20
Average Daily Volume: 113,382
Days Low: $0.16
Year Low: $0.08
Year High: $0.52
Adhera Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 05 2019 | ATRX | Adhera Therapeutic ... | Stanley Rhonda L. | SVP Finance & Accou ... | Option Exercise | A | 0.09 | 350,000 | 31,500 | 350,000 | |
| Apr 04 2019 | MRNA | Adhera Therapeutic ... | Phelan Nancy R. | CEO and Secretary | Option Exercise | A | 0.37 | 1,500,000 | 555,000 | 1,500,000 | |
| Jan 17 2019 | MRNA | Adhera Therapeutic ... | Teague Robert Eric | Chief Financial Off ... | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
| Oct 04 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Director | Sell | D | 0.50 | 500,000 | 250,000 | 612,716 | 1.1 M to 612.7 K (-44.94 %) |
| Sep 26 2018 | MRNA | Marina Biotech, In ... | Teague Robert Eric | Chief Financial Off ... | Option Exercise | A | 0.55 | 450,000 | 247,500 | 450,000 | |
| Jul 16 2018 | MRNA | Marina Biotech, In ... | Moscato Robert Jr. | Chief Executive Off ... | Option Exercise | P | 0.55 | 300,000 | 165,000 | 300,000 | |
| Jul 16 2018 | MRNA | Marina Biotech, In ... | Moscato Robert Jr. | Chief Executive Off ... | Option Exercise | P | 0.50 | 40 | 20 | 40 | |
| Jul 12 2018 | MRNA | Marina Biotech, In ... | Emerson Erik | Chief Commercial Of ... | Option Exercise | A | 0.66 | 1,125,000 | 742,500 | 1,125,000 | |
| Jul 11 2018 | MRNA | Marina Biotech, In ... | Hacksell Uli | Director | Option Exercise | A | 0.66 | 1,000,000 | 660,000 | 1,000,000 | |
| Jul 11 2018 | MRNA | Marina Biotech, In ... | Moscato Robert Jr. | Chief Executive Off ... | Option Exercise | A | 0.66 | 1,500,000 | 990,000 | 1,500,000 | |
| May 04 2018 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Option Exercise | A | 0.98 | 100,000 | 98,000 | 100,000 | ||
| May 04 2018 | MRNA | Marina Biotech, In ... | Calais Philippe | Option Exercise | A | 0.98 | 80,000 | 78,400 | 80,000 | ||
| May 04 2018 | MRNA | Marina Biotech, In ... | Ranker Philip C | Option Exercise | A | 0.98 | 200,000 | 196,000 | 200,000 | ||
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | P | 0.55 | 2,564,465 | 1,410,456 | 2,564,465 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | P | 0.50 | 163 | 82 | 163 |